The global market for contrast-enhanced Digital Mammography was valued at USD 1.3 billion in 2022 and is projected to reach USD 2.5 billion by 2032, with a rapid revenue Compound Annual Growth Rate (CAGR) of 7.5% during the forecast period. Key drivers for this market growth include the increasing prevalence of breast cancer, growing public awareness of early breast cancer detection, and advancements in Breast Imaging technology.
Breast cancer is one of the most common cancers among women, and early detection is crucial for effective treatment. According to the World Health Organization (WHO), breast cancer is anticipated to account for 11.7% of all new cancer cases in 2020, making it the second most prevalent cancer among women globally. The demand for digital mammography is rising due to the enhanced accuracy and sensitivity of contrast-enhanced digital mammography devices compared to traditional mammography systems.
Furthermore, the growing public awareness of the benefits of early breast cancer detection and increased government initiatives for breast cancer screening programs are expected to further boost market revenue during the forecast period. Various healthcare organizations and government agencies worldwide are promoting breast cancer screening programs to raise awareness and promote early detection. For example, Australia’s National Breast Cancer Screening Program offers free mammograms every two years to women aged 50 to 74. Such initiatives are expected to drive the demand for contrast-enhanced digital mammography systems.
Additionally, technological advancements in breast imaging play a significant role in driving market revenue growth. Contrast-enhanced digital mammography systems, which use contrast agents to highlight abnormal blood vessels in breast tumors, enhance the accuracy of breast cancer diagnosis. The introduction of advanced contrast agents like Iodine and gadolinium-based agents has further improved the accuracy of breast cancer diagnosis, leading to increased demand for contrast-enhanced digital mammography equipment.
Breast cancer accounts for 27% of all cancers among women in India, according to the WHO, making it the most prevalent disease in this population. Similarly, with an estimated 280,000 new cases reported each year, breast cancer is the second most common malignancy among women in China. However, the high cost of contrast-enhanced digital mammography equipment and a shortage of qualified personnel to operate these systems are significant factors that could hinder market revenue growth. Many healthcare facilities, especially in underdeveloped nations, are unable to afford these systems due to their high price.
Get a sample of the report @ https://www.reportsanddata.com/download-free-sample/7005
- Hologic, Inc.
- General Electric Company
- Siemens Healthineers AG
- Fujifilm Holdings Corporation
- Koninklijke Philips N.V.
- Danaher Corporation
- Aurora Imaging Technology, Inc.
- Planmed Oy
- Allengers Medical Systems Limited
- GE Healthcare
Factors Affecting of Contrast Enhanced Digital Mammography Market
The Contrast Enhanced Digital Mammography (CEDM) market is influenced by a variety of factors that impact its growth, adoption, and development. Understanding these factors is crucial for stakeholders, including healthcare providers, manufacturers, and investors. Here are some of the key factors affecting the Contrast Enhanced Digital Mammography market:
- Technological Advancements: Advances in imaging technology, including improvements in contrast agents and digital imaging systems, play a pivotal role in the CEDM market. As technology evolves, it can enhance image quality, reduce radiation exposure, and improve diagnostic accuracy.
- Breast Cancer Incidence and Awareness: The prevalence of breast cancer and increased awareness of the importance of early detection drive the demand for mammography techniques like CEDM. Rising breast cancer rates and screening campaigns contribute to market growth.
- Regulatory Environment: Stringent regulatory requirements and approvals for medical devices, including CEDM systems, can impact market entry and product development timelines. Adherence to regulatory standards is crucial for market players.
- Reimbursement Policies: The availability of reimbursement for CEDM procedures can significantly influence its adoption. Favorable reimbursement policies can encourage healthcare providers to invest in CEDM technology.
- Cost and Accessibility: The cost of CEDM equipment and accessibility to this technology can be barriers to adoption. Market growth may be influenced by efforts to reduce costs, increase availability, and expand CEDM services to underserved regions.
- Competitive Landscape: Competition among manufacturers and vendors in the CEDM market can lead to innovation, price competition, and improved product offerings. Market dynamics are influenced by the presence of major players and their strategies.
- Patient Preferences and Comfort: Patient comfort and preferences also impact the adoption of CEDM. Efforts to make the procedure more comfortable and less intimidating can influence its acceptance among patients.
- Clinical Evidence and Guidelines: Clinical studies and guidelines from medical associations and institutions can shape the adoption of CEDM. Positive research outcomes and recommendations can drive healthcare providers to integrate CEDM into their breast cancer screening protocols.
- Healthcare Infrastructure: The availability of healthcare facilities, trained personnel, and infrastructure to support CEDM procedures can affect its adoption. Investment in healthcare infrastructure can expand the market.
- Global Demographics: Population demographics, such as an aging population and increased life expectancy, can drive the need for breast cancer screening methods like CEDM, especially in regions with aging populations.
- Patient Education and Awareness: Public awareness campaigns and education initiatives can influence patient preferences for screening methods. Well-informed patients may request CEDM as part of their breast cancer screening.
- Integration with Healthcare IT: Integration with healthcare information technology (IT) systems and electronic health records (EHRs) can streamline the workflow and data management associated with CEDM, making it more appealing to healthcare providers.
In summary, the Contrast Enhanced Digital Mammography market is shaped by a combination of technological advancements, regulatory factors, patient preferences, healthcare infrastructure, and market competition. Stakeholders should closely monitor these factors to make informed decisions and contribute to the growth of CEDM as a valuable breast cancer screening tool.
To know more about the report @ https://www.reportsanddata.com/report-detail/contrast-enhanced-digital-mammography-market
Segments covered in the report:
Segments covered by Application Outlook, End-use Industry, Regional Outlook
By Product Type Outlook
By Technology Outlook
- Two Dimensional (2D)
- Three Dimensional (3D)
By End-Use Outlook
- Diagnostic Centers
- Research Institutes
- North America (U.S.A., Canada, Mexico)
- Europe (Italy, U.K., Germany, France, Rest of Europe)
- Asia Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
- Latin America (Chile, Brazil, Argentina, Peru, Rest of Latin America)
- Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)
Request a customization on the report @ https://www.reportsanddata.com/request-customization-form/7005
Thank you for taking the time to read our article. The report can be tailored to the needs of the client. Please contact us for more details, and our team will tailor the report to your specific requirements.
Explore Trending Report:
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyse consumer behaviour shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Power and Energy, and Chemicals. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market.
(Head of Business Development)
Reports and Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: [email protected]
Browse More Upcoming Reports @ https://www.reportsanddata.com/upcoming-reports
Browse More Latest Reports @ https://www.reportsanddata.com/report
Browse Latest Blogs: https://www.reportsanddata.com/blogs
Browse Latest Press Release: https://www.reportsanddata.com/press-release
Browse Upcoming Reports: https://www.reportsanddata.com/upcoming-reports